Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn ΔIAjxn)

Mathew Bull, Mei Methawasin, Joshua Strom, Pooja Nair, Kirk Hutchinson, Hendrikus "Henk" Granzier

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Rationale: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. Objective: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. Methods and Results: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn ΔIAjxn background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn ΔIAjxn mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. Conclusions: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.

Original languageEnglish (US)
Pages (from-to)764-772
Number of pages9
JournalCirculation Research
Volume119
Issue number6
DOIs
StatePublished - Sep 2 2016

Fingerprint

Connectin
Genetic Models
Alternative Splicing
Heart Failure
Protein Isoforms
Cardiac Myocytes
Exercise Tolerance
Ventricular Pressure
Post Translational Protein Processing
Hypertrophy
Compliance
RNA-Binding Motifs
Pharmacology
Exercise

Keywords

  • compliance
  • diastole
  • diastolic heart failure
  • hypertrophy
  • myocardium

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn ΔIAjxn). / Bull, Mathew; Methawasin, Mei; Strom, Joshua; Nair, Pooja; Hutchinson, Kirk; Granzier, Hendrikus "Henk".

In: Circulation Research, Vol. 119, No. 6, 02.09.2016, p. 764-772.

Research output: Contribution to journalArticle

Bull, Mathew ; Methawasin, Mei ; Strom, Joshua ; Nair, Pooja ; Hutchinson, Kirk ; Granzier, Hendrikus "Henk". / Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn ΔIAjxn). In: Circulation Research. 2016 ; Vol. 119, No. 6. pp. 764-772.
@article{f066613c092944478712c96a16b5d9b5,
title = "Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn ΔIAjxn)",
abstract = "Rationale: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. Objective: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. Methods and Results: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn ΔIAjxn background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn ΔIAjxn mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. Conclusions: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.",
keywords = "compliance, diastole, diastolic heart failure, hypertrophy, myocardium",
author = "Mathew Bull and Mei Methawasin and Joshua Strom and Pooja Nair and Kirk Hutchinson and Granzier, {Hendrikus {"}Henk{"}}",
year = "2016",
month = "9",
day = "2",
doi = "10.1161/CIRCRESAHA.116.308904",
language = "English (US)",
volume = "119",
pages = "764--772",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Alternative splicing of titin restores diastolic function in an HFpEF-like genetic murine model (Ttn ΔIAjxn)

AU - Bull, Mathew

AU - Methawasin, Mei

AU - Strom, Joshua

AU - Nair, Pooja

AU - Hutchinson, Kirk

AU - Granzier, Hendrikus "Henk"

PY - 2016/9/2

Y1 - 2016/9/2

N2 - Rationale: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. Objective: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. Methods and Results: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn ΔIAjxn background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn ΔIAjxn mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. Conclusions: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.

AB - Rationale: Patients with heart failure with preserved ejection fraction (HFpEF) experience elevated filling pressures and reduced ventricular compliance. The splicing factor RNA-binding motif 20 (RBM20) regulates the contour length of titin's spring region and thereby determines the passive stiffness of cardiomyocytes. Inhibition of RBM20 leads to super compliant titin isoforms (N2BAsc) that reduce passive stiffness. Objective: To determine the therapeutic potential of upregulating compliant titin isoforms in an HFpEF-like state in the mouse. Methods and Results: Constitutive and inducible cardiomyocyte-specific RBM20-inhibited mice were produced on a Ttn ΔIAjxn background to assess the effect of upregulating compliant titin at the cellular and organ levels. Genetic deletion of the I-band-A-band junction (IAjxn) in titin increases strain on the spring region and causes a HFpEF-like syndrome in the mouse without pharmacological or surgical intervention. The increased strain represents a mechanical analog of deranged post-translational modification of titin that results in increased passive myocardial stiffness in patients with HFpEF. On inhibition of RBM20 in Ttn ΔIAjxn mice, compliant titin isoforms were expressed, diastolic function was normalized, exercise performance was improved, and pathological hypertrophy was attenuated. Conclusions: We report for the first time a benefit from upregulating compliant titin isoforms in a murine model with HFpEF-like symptoms. Constitutive and inducible RBM20 inhibition improves diastolic function resulting in greater tolerance to exercise. No effective therapies exists for treating this pervasive syndrome; therefore, our data on RBM20 inhibition are clinically significant.

KW - compliance

KW - diastole

KW - diastolic heart failure

KW - hypertrophy

KW - myocardium

UR - http://www.scopus.com/inward/record.url?scp=84980407610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84980407610&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.116.308904

DO - 10.1161/CIRCRESAHA.116.308904

M3 - Article

C2 - 27470639

AN - SCOPUS:84980407610

VL - 119

SP - 764

EP - 772

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 6

ER -